Cite
HARVARD Citation
Guerci, B. et al. (2022). The Real‐World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Patients with Type 2 Diabetes (TROPHIES): Patient disposition, clinical characteristics and treatment persistence at 12 months. Diabetes, obesity & metabolism. 24 (12), pp. 2373-2382. [Online].